|
|
|
|
|
|
|
|
|
|
|
|
|
04.03.26 - 14:36
|
Charles River Associates (CRA) Strengthens Its Testifying Capabilities with the Addition of a Renowned Digital Economy Expert (Business Wire)
|
|
|
BOSTON--(BUSINESS WIRE)--Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announced the addition of Dr. Steven Tadelis as a Senior Consultant to the firm's Antitrust & Competition Economics Practice.
Dr. Tadelis is Professor of Economics, Business and Public Policy and the Sarin Chair in Leadership and Strategy at UC Berkeley's Haas School of Business. With research focused on e-commerce and internet economics, Dr. Tadelis has published extensively including field‑experiment analyses of digital advertising effectiveness, studies of reputation and feedback systems in online marketplaces, and research on algorithmic pricing. He has provided expert economic testimony in major US and Canadian litigation cases involving digital markets and participated in Federal Trade Commission hearings on competition and consumer protection.
“We are pleased to welcome Steve to CRA,” said Paul Maleh, President and Chief Executive O...
|
|
|
|
|
26.02.26 - 14:09
|
Charles River Associates (CRA) Reports Fourth-Quarter and Full-Year 2025 Financial Results (Business Wire)
|
|
|
Fourth Quarter Revenue Increases 11.6% Year Over Year
Broad-based Contributions Drive Record Revenue and Profitability in Fiscal 2025
Board Expands Share Repurchase Authorization by $55 MillionBOSTON--(BUSINESS WIRE)--Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial and management consulting services, today announced financial results for the fourth quarter and fiscal year ended January 3, 2026.
“For the eighth consecutive year, CRA established a new record for annual revenue,” said Paul Maleh, CRA's President and Chief Executive Officer. “Strong top-line growth drove record profitability as net income, earnings per diluted share, and EBITDA each set a new annual high. For the fourth quarter, we continued to see strength across our portfolio of services as total revenue increased 11.6% year over year to $197.0 million. Four practices—Antitrust & Competition Economics, Energy, Forensic Services, and Labor & Employment—led the way, with each generating ...
|
|
|
26.02.26 - 14:03
|
Charles River Associates (CRA) Declares Quarterly Cash Dividend of $0.57 Per Common Share (Business Wire)
|
|
|
BOSTON--(BUSINESS WIRE)--Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial and management consulting services, today announced that its Board of Directors has declared a quarterly cash dividend of $0.57 per common share to be paid on March 20, 2026 to shareholders of record of CRA's common stock as of the close of business on March 10, 2026. The Company expects to continue paying quarterly dividends, the declaration, timing and amounts of which remain subject to the discretion of CRA's Board of Directors.
About Charles River Associates (CRA)
Charles River Associates® is a leading global consulting firm specializing in economic, financial and management consulting services. CRA advises clients on economic and financial matters pertaining to litigation and regulatory proceedings, and guides corporations through critical business strategy and performance-related issues. Since 1965, clients have engaged CRA for its unique combination of functional expertise and in...
|
|
|
26.02.26 - 12:24
|
IQVIA to acquire Charles River drug discovery assets (PBR)
|
|
|
The acquisition includes five sites specialising in various in vitro drug discovery services such as New Approach Methodologies (NAMs) and a small molecule AI platform. These assets are
The post IQVIA to acquire Charles River drug discovery assets appeared first on Pharmaceutical Business review....
|
|
|
25.02.26 - 20:12
|
Harvard′s Massive Bet on Land Hits Harsh Real Estate Reality (Bloomberg)
|
|
|
A biotech downturn and pulled federal funds have stymied the university's property bet in Boston's Allston neighborhood — while nearby MIT has thrived. Harvard had little room for growth in Cambridge, its home since the 1600s. But just across the Charles River sat Allston, a working-class Boston neighborhood where the university had assembled hundreds of acres of land. There, Summers envisioned developing a sort of Silicon Valley of the East — a worthy competitor to California's Stanford University and the nearby Massachusetts Institute of Technology for high-tech innovation. Bloomberg's Janet Lorin joins to discuss. (Source: Bloomberg)...
|
|
|
|
|
|
|
25.02.26 - 13:06
|
IQVIA Signs Agreement to Acquire Drug Discovery Assets from Charles River Laboratories, Expanding End-to-End Drug Discovery Capabilities (Business Wire)
|
|
|
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced it has entered into an agreement to acquire certain discovery services assets from Charles River Laboratories.
These assets include five sites specializing in a range of in vitro drug discovery services, including established laboratory based New Approach Methodologies (NAMs) and a small molecule AI platform, designed to accelerate discovery programs and support growing demand for non animal research methods. Collectively, these assets are underpinned by more than 20 years of curated scientific and operational data, as well as extensive therapeutic expertise. Since their inception, these assets have enabled over 100 molecules to enter clinical trials and include several commercially approved drugs.
The acquisition complements IQVIA Laboratories' existing drug discove...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
